Dr Bruce Clark Offers Genomics and Aging Leadership Workshop
Astonishing change is transforming health care as we know it — and it goes beyond healthcare reform.
Dr Bruce Clark joins with Health Strategies Group to offer corporate leaders and decision-makers tools for responding to this change.The population of the U.S. is rapidly aging and the impact of genomic medicine is growing significantly. These two trends, and their “tributaries”, will transform the future of health care as we know it. Insofar as healthcare is an industry, and healthcare providers must stay competitive — questions abound regarding the best means of preparing for these “disruptive” new scenarios.
Companies want to know how to keep their board members and executive team on the cutting edge with regard to transformative currents shaping the future of health care. To answer this dilemma, Initially developed for and presented at The Governance Institute, this half-day “executive briefing” features the nation’s leading authorities on genomics and aging and is now available for your organization’s board retreat or other executive strategy session.
The expert faculty of genomics and aging experts is led by Bruce Clark, D.P.H., co-founder of Age Wave and Impact Presentations Group. Considered one of the nation’s foremost authorities on the business implications of an aging society, Dr. Clark’s team is well equipped to educate company decision-makers on topics such as the new supply in genomics medicine and demands of the new mature consumer.As waves of discovery in biotechnology and genomics gain force, significant implications arise for all health care sectors. Genomics topics include: the convergence of genomics, robotics, and nanotechnologies; widening use of genomic drug interventions, reclassification of therapeutic modalities and the revolution taking place in testing and personalized medicine. Topics addressed in the “New Supply” module include: how reform will redefine the private health insurance model; the rise of an “ownership” society; the impact of the substantial expansion of services available; skewing of optimal and cost-effective assessments of health status; greatly activated consumers.
Through this discussion, attendees will receive a broad and detailed picture of biotechnology today and how it fits into the context of our health care system.That context also includes an increasing number of mature Americans – and, in particular, more mature Americans spending more on healthcare (including discretionary spending). The “New Demand” module will include: Generations of Medicine, a multi-media exploration of who we have been and who we’re becoming; explanations of four trends that will transform the future of healthcare and two trends changing the healthcare consumer; new research on the defining characteristics of the “new mature consumer”; health information technology and the older consumer; what the longevity revolution means for the concept of growing old; the use of consumer choice models and retail health markets; the task of healthcare decision-making in a multi-generational society, and ten crises health care leadership will face in post-reform America.
For more information please contact email@example.com.